Tax O Bid 1gm Injection
By Tax O Bid
Rx
1 Injection in a Vial

Composition
Cefotaxime(1gm)

Manufacturer - Orchid Chemicals & Pharmaceuticals Ltd
Orchid Towers', #313, Valluvar Kottam High Road, Nungambakkam, Chennai - 600 034, Tamil Nadu, India

Expires on or after
October, 2025

liver
When it comes to the safety of using Tax O Bid 1gm Injection for patients with liver disease, it has been determined that it is safe to do so without requiring any dose adjustments. This means that patients with liver issues can use Tax O Bid 1gm Injection without worrying about any specific changes needed due to their condition. It is reassuring to know that the use of Tax O Bid 1gm Injection does not pose any additional risks or concerns for individuals with liver disease.

kidney
Caution should be taken when using Tax O Bid 1gm Injection in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor and undergo regular kidney function monitoring while on this medication.

alcohol
It is safe to consume alcohol while taking Tax O Bid 1gm Injection as it does not have any harmful side effects.

driving
When using Tax O Bid 1gm Injection, be cautious while driving as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Tax O Bid 1gm Injection is generally safe for use during pregnancy based on animal studies indicating minimal risk to the baby, although human studies are limited.

breastfeeding
Tax O Bid 1gm Injection is considered safe during breastfeeding. Research indicates that only minimal amounts of the drug may pass into breastmilk, posing no harm to the baby. To prevent potential side effects like rash and diarrhea, avoid long-term use.
Habit Forming | No |
Chemical Class | Broad Spectrum (Third & fourth generation cephalosporins) |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Cephalosporins: 3 generation |
₹29.28
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024